4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000067
Chief Medical Officer sold 11,366 shares at $14.60 ($165,931)
- Chief Medical Officer acquired 6,348 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-06-12 | Option exercise 10b5-1 | +6,348 | $1.08 | $6,856 | 113,017 | D |
| Rodman David Malcom Chief Medical Officer | 2025-06-13 | Sale 10b5-1 | −11,366 | $14.60 | $165,931 | 101,651 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-06-12 | Option exercise · Stock Option 10b5-1 | −6,348 | 95,229 | D | ||
| Open-market sales · 11,366 sh · avg $14.60 · $165,931 | |||||||
Loading xslF345X05/wk-form4_1750104191.xml…